Merck is the pharmaceutical company that makes a medication called pembrolizumab (Keytruda), which is used to treat different ...

Biosimilars are near-identical versions of biologic cancer drugs, available at lower costs. Germany saves hundreds of millions annually from just one biosimilar drug. Patient mistrust and policy ...

Clayton Irvine, PharmD, MBA, MS, senior manager of oncology care at Mayo Clinic, emphasizes the need for health care providers to balance quality patient care with rising costs by openly discussing ...

Nearly half of employers that track condition-specific data cite cancer as the No. 1 contributor to higher healthcare expenses, according to the 2025 Brown & Brown Employer Health and Benefits ...

Add Yahoo as a preferred source to see more of our stories on Google. A cancer diagnosis increases privately insured patients' monthly out-of-pocket costs, which also rise as the disease progresses, ...

Cancer remains employers' top unmanaged cost risk, yet new analysis of two studies shows it continues to lose daily executive focus to other health concerns, such as GLP‑1s and mental health. This ...

A partitioned-survival lifetime model (2025 USD) compared ADT alone with seven intensification strategies across PFS, post-progression, and death, using published survival curves and literature-based ...

While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the ...

When Danny Hoyland was diagnosed with stage III colorectal cancer in February 2025, the first stage of treatment for the 40-year-old father of two was immediate, aggressive chemotherapy followed by a ...